{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:32:18Z","timestamp":1759336338134,"version":"3.41.2"},"reference-count":81,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold>Chronic infection with<jats:italic>Toxoplasma gondii<\/jats:italic>(TOXO) results in microcysts in the brain that are controlled by inflammatory activation and subsequent changes in the kynurenine pathway. TOXO seropositivity is associated with a heightened risk of schizophrenia (SCZ) and with cognitive impairments. Latency of the acoustic startle response, a putative index of neural processing speed, is slower in SCZ. SCZ subjects who are TOXO seropositive have slower latency than SCZ subjects who are TOXO seronegative. We assessed the relationship between kynurenine pathway metabolites and startle latency as a potential route by which chronic TOXO infection can lead to cognitive slowing in SCZ.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold>Fourty-seven SCZ subjects and 30 controls (CON) were tested on a standard acoustic startle paradigm. Kynurenine pathway metabolites were measured using liquid chromatography-tandem mass spectrometry were kynurenine (KYN), tryptophan (TRYP), 3-hydroxyanthranilic acid (3-OHAA), anthranilic acid (AA), and kynurenic acid (KYNA). TOXO status was determined by IgG ELISA.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold>In univariate ANCOVAs on onset and peak latency with age and log transformed startle magnitude as covariates, both onset latency [F<jats:sub>(1,61)<\/jats:sub>= 5.76;<jats:italic>p<\/jats:italic>= 0.019] and peak latency [F<jats:sub>(1,61)<\/jats:sub>= 4.34;<jats:italic>p<\/jats:italic>= 0.041] were slower in SCZ than CON subjects. In stepwise backward linear regressions after stratification by Diagnosis, slower onset latency in SCZ subjects was predicted by higher TRYP (B = 0.42;<jats:italic>p<\/jats:italic>= 0.008) and 3-OHAA:AA (B = 3.68;<jats:italic>p<\/jats:italic>= 0.007), and lower KYN:TRYP (B = \u2212185.42;<jats:italic>p<\/jats:italic>= 0.034). In regressions with peak latency as the dependent variable, slower peak latency was predicted by higher TRYP (B = 0.47;<jats:italic>p<\/jats:italic>= 0.013) and 3-OHAA:AA ratio (B = 4.35;<jats:italic>p<\/jats:italic>= 0.010), and by lower KYNA (<jats:italic>B<\/jats:italic>= \u22126.67;<jats:italic>p<\/jats:italic>= 0.036). In CON subjects neither onset nor peak latency was predicted by any KYN metabolites. In regressions stratified by TOXO status, in TOXO positive subjects, slower peak latency was predicted by lower concentrations of KYN (B = \u22128.08;<jats:italic>p<\/jats:italic>= 0.008), KYNA (B = \u221210.64;<jats:italic>p<\/jats:italic>= 0.003), and lower KYN:TRYP ratios (B = \u2212347.01;<jats:italic>p<\/jats:italic>= 0.03). In TOXO negative subjects neither onset nor peak latency was predicted by any KYN metabolites.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold>KYN pathway markers predict slowing of startle latency in SCZ subjects and in those with chronic TOXO infection, but this is not seen in CON subjects nor TOXO seronegative subjects. These findings coupled with prior work indicating a relationship of slower latency with SCZ and TOXO infection suggest that alterations in KYN pathway markers may be a mechanism by which neural processing speed, as indexed by startle latency, is affected in these subjects.<\/jats:p>","DOI":"10.3389\/fpsyt.2020.552743","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T06:28:55Z","timestamp":1605853735000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Toxoplasma gondii Effects on the Relationship of Kynurenine Pathway Metabolites to Acoustic Startle Latency in Schizophrenia vs. Control Subjects"],"prefix":"10.3389","volume":"11","author":[{"given":"Bradley D.","family":"Pearce","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Massa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Goldsmith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeal H.","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Hankus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaaeddin","family":"Alrohaibani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha","family":"Goel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Cuthbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly","family":"Fargotstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana Boyd","family":"Barr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parinya","family":"Panuwet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria M.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/acps.12423","article-title":"Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis","volume":"132","author":"Sutterland","year":"2015","journal-title":"Acta Psychiatr Scand."},{"key":"B2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fpsyt.2020.00072","article-title":"Schizophrenia and influenza at the centenary of the 1918\u20131919 Spanish influenza pandemic: mechanisms of psychosis risk","volume":"11","author":"Kepinska","year":"2020","journal-title":"Front Psychiatry."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","article-title":"Toxoplasma gondii: from animals to humans","volume":"30","author":"Tenter","year":"2000","journal-title":"Int J Parasitol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/aje\/154.4.357","article-title":"Toxoplasma gondii infection in the United States: seroprevalence and risk factors","volume":"154","author":"Jones","year":"2001","journal-title":"Am J Epidemiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.4269\/ajtmh.14-0013","article-title":"Toxoplasma gondii seroprevalence in the United States 2009\u20132010 and comparison with the past two decades","volume":"90","author":"Jones","year":"2014","journal-title":"Am J Trop Med Hyg."},{"key":"B6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.14411\/fp.2010.011","article-title":"Manipulation of host behaviour by Toxoplasma gondii: what is the minimum a proposed proximate mechanism should explain?","volume":"57","author":"Vyas","year":"2010","journal-title":"Folia Parasitol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.14411\/fp.2010.012","article-title":"Toxoplasma gondii-altered host behaviour: clues as to mechanism of action","volume":"57","author":"Webster","year":"2010","journal-title":"Folia Parasitol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bbr.2006.11.012","article-title":"Toxoplasma gondii infection lower anxiety as measured in the plus-maze and social interaction tests in rats A behavioral analysis","volume":"177","author":"Gonzalez","year":"2007","journal-title":"Behav Brain Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"6442","DOI":"10.1073\/pnas.0608310104","article-title":"Behavioral changes induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors","volume":"104","author":"Vyas","year":"2007","journal-title":"P Natl Acad Sci USA."},{"key":"B10","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/schbul\/sbl050","article-title":"Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis","volume":"33","author":"Torrey","year":"2007","journal-title":"Schizophr Bull."},{"key":"B11","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/mp.2008.5","article-title":"Are some cases of psychosis caused by microbial agents? A review of the evidence","volume":"13","author":"Yolken","year":"2008","journal-title":"Mol Psychiatry."},{"key":"B12","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/schbul\/sbs043","article-title":"Toxoplasma gondii and other risk factors for schizophrenia: an update","volume":"38","author":"Torrey","year":"2012","journal-title":"Schizophr Bull."},{"key":"B13","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1017\/S0031182001007624","article-title":"Decrease of psychomotor performance in subjects with latent 'asymptomatic' toxoplasmosis","volume":"122","author":"Havlicek","year":"2001","journal-title":"Parasitology."},{"key":"B14","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0301-0511(03)00075-9","article-title":"Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii Dopamine, a missing link between schizophrenia and toxoplasmosis?","volume":"63","author":"Flegr","year":"2003","journal-title":"Biol Psychol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/j.1365-3024.2009.01131.x","article-title":"Toxoplasma and schizophrenia","volume":"31","author":"Yolken","year":"2009","journal-title":"Parasite Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00127-014-0820-5","article-title":"The association of Toxoplasma gondii infection with neurocognitive deficits in a population-based analysis","volume":"49","author":"Pearce","year":"2014","journal-title":"Soc Psychiatry Psychiatr Epidemiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jad.2015.03.038","article-title":"Cognitive deterioration among bipolar disorder patients infected by Toxoplasma gondii is correlated to interleukin 6 levels","volume":"179","author":"Hamdani","year":"2015","journal-title":"J Affect Disord."},{"key":"B18","doi-asserted-by":"publisher","first-page":"103751","DOI":"10.1016\/j.micpath.2019.103751","article-title":"Is Toxoplasma gondii a potential risk factor for Alzheimer's disease? A systematic review and meta-analysis","volume":"137","author":"Chegeni","year":"2019","journal-title":"Microb Pathog."},{"key":"B19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12974-020-1721-z","article-title":"Effects of inflammation on the kynurenine pathway in schizophrenia\u2014a systematic review","volume":"17","author":"Pedraz-Petrozzi","year":"2020","journal-title":"J Neuroinflammation."},{"key":"B20","first-page":"1563","article-title":"A primary acoustic startle circuit: lesion and anatomical tracing studies","volume":"18","author":"Lee","year":"1992","journal-title":"Soc Neurosci Abstracts."},{"key":"B21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0301-0082(98)00098-7","article-title":"The neurobiology of startle","volume":"59","author":"Koch","year":"1999","journal-title":"Prog Neurobiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.psychres.2009.11.012","article-title":"Heritability of acoustic startle magnitude, prepulse inhibition, and startle latency in schizophrenia and control families","volume":"178","author":"Hasenkamp","year":"2010","journal-title":"Psychiatry Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/j.1469-8986.1978.tb01390.x","article-title":"Prestimulus effects on human startle reflex in normals and schizophrenics","volume":"14","author":"Braff","year":"1978","journal-title":"Psychophysiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1469-8986.1982.tb02589.x","article-title":"Habituation of the Blink reflex in normals and schizophrenic patients","volume":"19","author":"Geyer","year":"1982","journal-title":"Psychophysiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0920-9964(01)00198-0","article-title":"Stability of the acoustic startle reflex, prepulse inhibition, and habituation in schizophrenia","volume":"55","author":"Ludewig","year":"2002","journal-title":"Schizophr Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.schres.2019.11.013","article-title":"Relationship of prolonged acoustic startle latency to diagnosis and biotype in the bipolar-schizophrenia network on intermediate phenotypes (B-SNIP) co Relationship of prolonged acoustic startle latency to diagnosis and biotype in the bipolar-schizophrenia network on intermediate phenotypes (B-SNIP) cohort hort","volume":"216","author":"Massa","year":"2019","journal-title":"Schizophr Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1001\/archpsyc.63.12.1325","article-title":"Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function","volume":"63","author":"Swerdlow","year":"2006","journal-title":"Arch Gen Psychiatry."},{"key":"B28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.schres.2017.05.013","article-title":"Deficient prepulse inhibition in schizophrenia in a multi-site cohort: internal replication and extension","volume":"198","author":"Swerdlow","year":"2018","journal-title":"Schizophr Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0006-3223(99)00229-2","article-title":"Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients","volume":"47","author":"Weike","year":"2000","journal-title":"Biol Psychiatry."},{"key":"B30","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1176\/ajp.156.4.596","article-title":"Symptom correlates of prepulse inhibition deficits in male schizophrenic patients","volume":"156","author":"Braff","year":"1999","journal-title":"Am J Psychiatry."},{"key":"B31","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1001\/archpsyc.1992.01820030038005","article-title":"Gating and habituation of the startle reflex in schizophrenic patients","volume":"49","author":"Braff","year":"1992","journal-title":"Arch Gen Psychiatry."},{"key":"B32","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/S0006-3223(99)00148-1","article-title":"Impaired prepulse inhibition of acoustic startle in schizophrenics","volume":"47","author":"Parwani","year":"2000","journal-title":"Biol Psychiatry."},{"key":"B33","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S0006-3223(02)01409-9","article-title":"Effects of antipsychotics on prepulse inhibition of the startle response in drug-naive schizophrenic patients","volume":"52","author":"Mackeprang","year":"2002","journal-title":"Biol Psychiatry."},{"key":"B34","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3389\/fpsyt.2020.00833","article-title":"Evidence of slow neural processing, developmental differences and sensitivity to cannabis effects in a sample at clinical high risk for psychosis from the NAPLS Consortium assessed with the human startle paradigm","volume":"11","author":"Cadenhead","year":"2020","journal-title":"Front Psychiatry Schizophr Sect."},{"key":"B35","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.schres.2013.07.028","article-title":"Toxoplasma gondii exposure affects neural processing speed as measured by acoustic startle latency in schizophrenia and controls","volume":"150","author":"Pearce","year":"2013","journal-title":"Schizophr Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"S335","DOI":"10.1016\/j.biopsych.2020.02.612","article-title":"Toxoplasma gondii effects on the relationship of kynurenine pathway metabolites to cognition in schizophrenia versus control subjects","volume":"44","author":"Pearce","year":"2019","journal-title":"Neuropsychopharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1038\/sj.npp.1300188","article-title":"Micromolar brain levels of kynurenic acid are associated with a disruption of auditory sensory gating in the rat","volume":"28","author":"Shepard","year":"2003","journal-title":"Neuropsychopharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.biopsych.2004.06.006","article-title":"Endogenous kynurenic acid disrupts prepulse inhibition","volume":"56","author":"Erhardt","year":"2004","journal-title":"Biol Psychiatry."},{"key":"B39","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/schbul\/sbl033","article-title":"Elevations of endogenous kynurenic acid produce spatial working memory deficits","volume":"33","author":"Chess","year":"2007","journal-title":"Schizophr Bull."},{"key":"B40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.bbr.2009.03.013","article-title":"L-kynurenine treatment alters contextual fear conditioning and context discrimination but not cue-specific fear conditioning","volume":"201","author":"Chess","year":"2009","journal-title":"Behav Brain Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/schbul\/sbq002","article-title":"Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in Schizophrenia","volume":"36","author":"Wonodi","year":"2010","journal-title":"Schizophr Bull."},{"volume-title":"Structured Clinical interview for DSM-IV-TR Axis I Disorders.","year":"2001","author":"First","key":"B42"},{"key":"B43","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0306-4603(78)90024-2","article-title":"Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment","volume":"3","author":"Fagerstrom","year":"1978","journal-title":"Addict Behav."},{"key":"B44","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.schres.2017.07.030","article-title":"The effect of antipsychotic medications on acoustic startle latency in schizophrenia","volume":"198","author":"Fargotstein","year":"2018","journal-title":"Schizophr Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1469-0691.2006.01564.x","article-title":"Evaluation of a commercial IgE ELISA in comparison with IgA and IgM ELISAs, IgG avidity assay and complement fixation for the diagnosis of acute toxoplasmosis","volume":"13","author":"Kodym","year":"2007","journal-title":"Clin Microbiol Infect."},{"key":"B46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00213-008-1116-9","article-title":"Effects of tryptophan deficiency on prepulse inhibition of the acoustic startle in rats","volume":"198","author":"Bortolato","year":"2008","journal-title":"Psychopharmacology."},{"key":"B47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/BF01244833","article-title":"Effects of various direct or indirect dopamine agonists on the latency of the acoustic startle response in rats","volume":"82","author":"Naudin","year":"1990","journal-title":"J Neural Transmission."},{"key":"B48","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0014-2999(90)90160-8","article-title":"The role of the dopaminergic system in the modulation of the acoustic startle response in the rat","volume":"175","author":"Svensson","year":"1990","journal-title":"Eur J Pharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.biopsych.2008.01.020","article-title":"The dopamine D(3) receptor Ser9Gly polymorphism modulates prepulse inhibition of the acoustic startle reflex","volume":"64","author":"Roussos","year":"2008","journal-title":"Biol Psychiatry."},{"key":"B50","first-page":"200","article-title":"Antipsychotic drug actions: a clue to the neuropathology of schizophrenia?","volume":"32","author":"Matthysse","year":"1973","journal-title":"Fed Proc."},{"key":"B51","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1176\/ajp.133.2.197","article-title":"The dopamine hypothesis of schizophrenia: focus on the dopamine receptor","volume":"133","author":"Snyder","year":"1976","journal-title":"Am J Psychiatry."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","article-title":"Dopamine in schizophrenia: a review and reconceptualization","volume":"148","author":"Davis","year":"1991","journal-title":"Am J Psychiatry."},{"key":"B53","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The dopamine hypothesis of schizophrenia: version III\u2013the final common pathway","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophr Bull."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00406-007-0753-z","article-title":"Effects of experimental acute tryptophan depletion on acoustic startle response in females","volume":"258","author":"Norra","year":"2007","journal-title":"Eur Archiv Psychiatry Clin Neurosci."},{"key":"B55","first-page":"1059","article-title":"Anthranilic acid: a potential biomarker and treatment target for schizophrenia","volume":"4","author":"Oxenkrug","year":"2016","journal-title":"Ann Psychiatry Mental Health"},{"key":"B56","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.neuro.2012.11.007","article-title":"3-Hydroxykynurenine: an intriguing molecule exerting dual actions in the central nervous system","volume":"34","author":"Col\u00edn-Gonz\u00e1lez","year":"2013","journal-title":"Neurotoxicology."},{"key":"B57","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/s41386-020-0607-1","article-title":"Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression","volume":"45","author":"Haroon","year":"2020","journal-title":"Neuropsychopharmacology."},{"key":"B58","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/mp.2009.116","article-title":"CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression","volume":"15","author":"Raison","year":"2010","journal-title":"Mol Psychiatry."},{"key":"B59","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","article-title":"Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism","volume":"56","author":"Fukui","year":"1991","journal-title":"J Neurochem."},{"key":"B60","first-page":"309","article-title":"Neuropharmacology of quinolinic and kynurenic acids","volume":"45","author":"Stone","year":"1993","journal-title":"Pharmacol Rev."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.bbi.2011.05.005","article-title":"Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naive and medication-free schizophrenic patients","volume":"25","author":"Myint","year":"2011","journal-title":"Brain Behav Immunity."},{"key":"B62","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12640-017-9714-0","article-title":"Correlations of kynurenic acid, 3-hydroxykynurenine, sIL-2R, IFN-alpha, and IL-4 with clinical symptoms during acute relapse of Schizophrenia","volume":"32","author":"Szymona","year":"2017","journal-title":"Neurotox Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e1115","DOI":"10.1038\/tp.2017.88","article-title":"Serum kynurenic acid is reduced in affective psychosis","volume":"7","author":"Wurfel","year":"2017","journal-title":"Transl Psychiatry."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1038\/s41386-018-0038-4","article-title":"Influence of plasma cytokines on kynurenine and kynurenic acid in schizophrenia","volume":"43","author":"Chiappelli","year":"2018","journal-title":"Neuropsychopharmacology."},{"key":"B65","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0304-3940(01)02242-X","article-title":"Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia","volume":"313","author":"Erhardt","year":"2001","journal-title":"Neurosci Lett."},{"key":"B66","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.schres.2005.07.013","article-title":"Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia","volume":"80","author":"Nilsson","year":"2005","journal-title":"Schizophrenia Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/schbul\/sbq086","article-title":"Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia","volume":"38","author":"Linderholm","year":"2012","journal-title":"Schizophr Bull."},{"key":"B68","doi-asserted-by":"publisher","first-page":"S332","DOI":"10.1016\/j.biopsych.2018.02.854","article-title":"Cytokine levels correlate with slowed latency of acoustic startle and processing speed in schizophrenia","volume":"83","author":"Massa","year":"2018","journal-title":"Biol Psychiatry."},{"key":"B69","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00210-011-0605-2","article-title":"Different inhibitory effects of kynurenic acid and a novel kynurenic acid analogue on tumour necrosis factor-\u03b1 (TNF-\u03b1) production by mononuclear cells, HMGB1 production by monocytes and HNP1-3 secretion by neutrophils","volume":"383","author":"Tiszlavicz","year":"2011","journal-title":"Naunyn-Schmiedeberg's Archiv Pharmacol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tips.2012.09.006","article-title":"An expanding range of targets for kynurenine metabolites of tryptophan","volume":"34","author":"Stone","year":"2013","journal-title":"Trends Pharmacol Sci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1093\/schbul\/sbm010","article-title":"A controlled prospective study of toxoplasma gondii infection in individuals with schizophrenia: beyond seroprevalence","volume":"33","author":"Hinze-Selch","year":"2007","journal-title":"Schizophr Bull."},{"key":"B72","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.schres.2011.08.006","article-title":"Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia","volume":"133","author":"Okusaga","year":"2011","journal-title":"Schizophrenia Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.diagmicrobio.2015.09.009","article-title":"Serological diagnosis of Toxoplasma gondii infection: recommendations from the French National Reference Center for Toxoplasmosis","volume":"84","author":"Villard","year":"2016","journal-title":"Diagn Microbiol Infect Dis."},{"key":"B74","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.schres.2004.09.007","article-title":"Identification of separable cognitive factors in schizophrenia","volume":"72","author":"Nuechterlein","year":"2004","journal-title":"Schizophr Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/schbul\/sbl051","article-title":"Psychomotor slowing in schizophrenia","volume":"33","author":"Morrens","year":"2007","journal-title":"Schizophr Bull."},{"key":"B76","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1037\/0033-2909.133.5.833","article-title":"Neuropsychological impairments in schizophrenia: integration of performance-based and brain imaging findings","volume":"133","author":"Reichenberg","year":"2007","journal-title":"Psychol Bull."},{"key":"B77","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1176\/appi.ajp.2007.07010042","article-title":"The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity","volume":"165","author":"Nuechterlein","year":"2008","journal-title":"Am J Psychiatry."},{"key":"B78","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0006-3223(01)01078-2","article-title":"Increased cortical kynurenate content in schizophrenia","volume":"50","author":"Schwarcz","year":"2001","journal-title":"Biol Psychiatry."},{"key":"B79","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.brainres.2005.12.056","article-title":"Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder","volume":"4","author":"Miller","year":"2006","journal-title":"Brain Res."},{"key":"B80","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.neuropharm.2016.05.020","article-title":"The kynurenine pathway in schizophrenia and bipolar disorder","volume":"112","author":"Erhardt","year":"2017","journal-title":"Neuropharmacology."},{"key":"B81","doi-asserted-by":"publisher","first-page":"e4801","DOI":"10.1371\/journal.pone.0004801","article-title":"A unique dual activity amino acid hydroxylase in Toxoplasma gondii","volume":"4","author":"Gaskell","year":"2009","journal-title":"PLoS ONE"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2020.552743\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:04:48Z","timestamp":1669680288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2020.552743\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,20]]},"references-count":81,"alternative-id":["10.3389\/fpsyt.2020.552743"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2020.552743","relation":{},"ISSN":["1664-0640"],"issn-type":[{"type":"electronic","value":"1664-0640"}],"subject":[],"published":{"date-parts":[[2020,11,20]]},"article-number":"552743"}}